医薬品原薬(API)市場レポート 医薬品タイプ(革新的医薬品原薬(API)、ジェネリック医薬品原薬(API))、メーカータイプ(専業メーカー、商社APIメーカー)、合成タイプ(合成医薬品原薬(API)、バイオ医薬品原薬(API))、治療用途(がん、循環器・呼吸器、糖尿病、中枢神経系疾患、神経疾患、その他)、地域別 2024-2032

医薬品原薬(API)市場レポート 医薬品タイプ(革新的医薬品原薬(API)、ジェネリック医薬品原薬(API))、メーカータイプ(専業メーカー、商社APIメーカー)、合成タイプ(合成医薬品原薬(API)、バイオ医薬品原薬(API))、治療用途(がん、循環器・呼吸器、糖尿病、中枢神経系疾患、神経疾患、その他)、地域別 2024-2032

Report Format: PDF+Excel | Report ID: SR112025A24851

Language of the Report – English

ただし、追加料金で日本語のレポートが入手できる場合もある。

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
     2.5   Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Active Pharmaceutical Ingredients (API) Market
    5.1    Market Overview
    5.2    Market Performance 
    5.3    Impact of COVID-19
    5.4    Market Breakup by Drug Type
    5.5    Market Breakup by Type of Manufacturer
    5.6    Market Breakup by Type of Synthesis 
    5.7    Market Breakup by Therapeutic Application
    5.8    Market Breakup by Region
    5.9    Market Forecast
    5.10    SWOT Analysis
        5.10.1    Overview
        5.10.2    Strengths
        5.10.3    Weaknesses
        5.10.4    Opportunities
        5.10.5    Threats
    5.11    Value Chain Analysis
    5.12    Porters Five Forces Analysis
        5.12.1    Overview
        5.12.2    Bargaining Power of Buyers
        5.12.3    Bargaining Power of Suppliers
        5.12.4    Degree of Competition
        5.12.5    Threat of New Entrants
        5.12.6    Threat of Substitutes
    5.13    Price Analysis
        5.13.1    Price Indicators
        5.13.2    Price Structure
6   Market Breakup by Drug Type
    6.1    Innovative Active Pharmaceutical Ingredients (API)
    6.2    Generic Active Pharmaceutical Ingredients (API)
7   Market Breakup by Type of Manufacturer
    7.1    Captive Manufacturers 
    7.2    Merchant API Manufacturers 
        7.2.1   Innovative Merchant API Manufacturers
        7.2.2   Generic Merchant API Manufacturers   
8   Market Breakup by Type of Synthesis 
    8.1    Synthetic Active Pharmaceutical Ingredients (API)
        8.1.1    Market Breakup by Type
           8.1.1.1 Innovative Synthetic APIs
           8.1.1.2 Generic Synthetic APIs
    8.2    Biotech Active Pharmaceutical Ingredients (API)
        8.2.1    Market Breakup by Type
           8.2.1.1 Innovative Biotech APIs
           8.2.1.2 Biosimilars
        8.2.2    Market Breakup by Product 
           8.2.2.1 Monoclonal Antibodies 
           8.2.2.2 Vaccines 
           8.2.2.3 Cytokines 
           8.2.2.4 Fusion Proteins 
           8.2.2.5 Therapeutic Enzymes 
           8.2.2.6 Blood Factors
        8.2.3   Market Breakup by Expression System 
           8.2.3.1 Mammalian Expression Systems 
           8.2.3.2 Microbial Expression Systems
           8.2.3.3 Yeast Expression Systems 
           8.2.3.4 Transgenic Animal Systems
           8.2.3.5 Others
9   Market Breakup by Therapeutic Application
    9.1    Oncology
    9.2    Cardiovascular and Respiratory
    9.3    Diabetes 
    9.4    Central Nervous System Disorders
    9.5    Neurological Disorders  
    9.6    Others
10  Market Breakup by Region
    10.1    North America 
        10.1.1 United States
        10.1.2 Canada
    10.2    Europe
        10.2.1 Germany
        10.2.2 France
        10.2.3 United Kingdom
        10.2.4 Italy
        10.2.5 Spain
        10.2.6 Russia
        10.2.7 Others
    10.3    Asia Pacific
        10.3.1 China
        10.3.2 Japan
        10.3.3 India
        10.3.4 South Korea
        10.3.5 Australia
        10.3.6 Indonesia
        10.3.7 Others
    10.4    Latin America    
    10.5    Middle East and Africa
11  API Manufacturing Process
    11.1    Product Overview
    11.2    Raw Material Requirements
    11.3    Manufacturing Process
    11.4    Key Success and Risk Factors
12  Competitive Landscape
    12.1    Market Structure
    12.2    Key Players
    12.3    Profiles of Key Players
        12.3.1    Pfizer, Inc. 
        12.3.2    Novartis International AG 
        12.3.3    Sanofi 
        12.3.4    Boehringer Ingelheim 
        12.3.5    Bristol-Myers Squibb 
        12.3.6    Teva Pharmaceutical Industries Ltd.  
        12.3.7    ELI Lilly and Company 
        12.3.8    GlaxoSmithKline 
        12.3.9    Merck & Co., Inc. 
        12.3.10    Abbvie Inc

医薬品原薬(API)市場レポート 医薬品タイプ(革新的医薬品原薬(API)、ジェネリック医薬品原薬(API))、メーカータイプ(専業メーカー、商社APIメーカー)、合成タイプ(合成医薬品原薬(API)、バイオ医薬品原薬(API))、治療用途(がん、循環器・呼吸器、糖尿病、中枢神経系疾患、神経疾患、その他)、地域別 2024-2032
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials